InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Bumpus Namandje. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 5 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €13k. History available since 17 March 2025. The latest transaction was filed on 3 June 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Bumpus Namandje is a declarant linked to Recursion Pharmaceuticals, INC., where he is Director. He has 5 filings in total, and among the sampled recent filings, sales total 13368 EUR, with filings dated from 2025-03-19 to 2026-06-22.